Ascorbate in aqueous humor augments nitric oxide production by macrophages

Journal of Immunology

Volumn 190, Issue 2, 2013, Pages 556-564

  McKenna, Kyle C ^a,b   Beatty, Kelly M ^a   Scherder, Rebecca C ^a   Li, Fuwang ^c   Liu, Huanbo ^c   Chen, Alex F ^c   Ghosh, Arnab ^d   Stueh, Dennis J ^d  

^a University of Pittsburgh School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; AMINO ACID TRANSPORTER; AMINO ACID TRANSPORTER 2B; ARGINASE; ARGINASE 1; ARGINASE 2; ARGININE; ASCORBIC ACID; CALCITONIN GENE RELATED PEPTIDE; CITRULLINE; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HOMODIMER; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRITE; PIGMENT EPITHELIUM DERIVED FACTOR; TETRAHYDROBIOPTERIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; AQUEOUS HUMOR; ARTICLE; BIOTRANSFORMATION; CELL LEVEL; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; MACROPHAGE; MALE; MICROENVIRONMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; SUPERNATANT;

ALPHA-MSH; AMINO ACID TRANSPORT SYSTEMS, BASIC; ANIMALS; AQUEOUS HUMOR; ARGINASE; ARGININE; ASCORBIC ACID; BIOLOGICAL TRANSPORT; BIOPTERIN; CALCITONIN GENE-RELATED PEPTIDE; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GTP CYCLOHYDROLASE; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NERVE GROWTH FACTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN MULTIMERIZATION; RABBITS; SERPINS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84872198065     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201754     Document Type: Article

References (34)

1. Streilein, J. W. 2003. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3: 879-889.
2. Niederkorn, J. Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7: 354-359.
3. McKenna, K. C., and P. W. Chen. 2010. Influence of immune privilege on ocular tumor development. Ocul. Immunol. Inflamm. 18: 80-90.
4. McKenna, K. C., and J. A. Kapp. 2004. Ocular immune privilege and CTL tolerance. Immunol. Res. 29: 103-112.
5. Vicetti Miguel, R. D., T. L. Cherpes, L. J. Watson, and K. C. McKenna. 2010. CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination. J. Immunol. 185: 6706-6718.
6. Taylor, A. W. 2007. Ocular immunosuppressive microenvironment. Chem. Immunol. Allergy 92: 71-85.
7. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178: 605-613.
8. Star, R. A., N. Rajora, J. Huang, R. C. Stock, A. Catania, and J. M. Lipton. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92: 8016-8020.
9. Taylor, A. W., D. G. Yee, and J. W. Streilein. 1998. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Vis. Sci. 39: 1372-1378.
10. Nicholson, B., C. K. Manner, J. Kleeman, and C. L. MacLeod. 2001. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 276: 15881-15885.
11. Mori, M. 2007. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J. Nutr. 137(Suppl. 2): 1616S-1620S.
12. Bertholet, S., E. Tzeng, E. Felley-Bosco, and J. Mauël. 1999. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J. Leukoc. Biol. 65: 50-58.
13. Baek, K. J., B. A. Thiel, S. Lucas, and D. J. Stuehr. 1993. Macrophage nitric oxide synthase subunits: purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J. Biol. Chem. 268: 21120-21129.
14. Ratovitski, E. A., C. Bao, R. A. Quick, A. McMillan, C. Kozlovsky, and C. J. Lowenstein. 1999. An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J. Biol. Chem. 274: 30250-30257.
15. Ratovitski, E. A., M. R. Alam, R. A. Quick, A. McMillan, C. Bao, C. Kozlovsky, T. A. Hand, R. C. Johnson, R. E. Mains, B. A. Eipper, and C. J. Lowenstein. 1999. Kalirin inhibition of inducible nitric-oxide synthase. J. Biol. Chem. 274: 993-999.
16. Daniliuc, S., H. Bitterman, M. A. Rahat, A. Kinarty, D. Rosenzweig, and L. Nitza. 2003. Hypoxia inactivates inducible nitric oxide synthase in mouse macrophages by disrupting its interaction with alpha-actinin 4. J. Immunol. 171: 3225-3232.
17. Albakri, Q. A., and D. J. Stuehr. 1996. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J. Biol. Chem. 271: 5414-5421.
18. Du, Y. H., Y. Y. Guan, N. J. Alp, K. M. Channon, and A. F. Chen. 2008. Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 117: 1045-1054.
19. Cousins, S. W., M. M. McCabe, D. Danielpour, and J. W. Streilein. 1991. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32: 2201-2211.
20. Taylor, A. W. 2003. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol. Biol. 49: 143-149.
21. Yoshida, Y., S. Yamagishi, S. Ueda, K. Yoshimura, S. Okuda, and R. Yamakawa. 2007. Aqueous humour levels of asymmetric dimethylarginine (ADMA) are correlated with pigment epithelium-derived factor (PEDF) in patients with uveitis. J. Int. Med. Res. 35: 892-895.
22. Zamiri, P., S. Masli, J. W. Streilein, and A. W. Taylor. 2006. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci. 47: 3912-3918.
23. Racké, K., C. Hey, J. Mössner, R. Hammermann, C. Stichnote, and I. Wessler. 1998. Activation of L-arginine transport by protein kinase C in rabbit, rat and mouse alveolar macrophages. J. Physiol. 511: 813-825.
24. Salimuddin, A., A. Nagasaki, T. Gotoh, H. Isobe, and M. Mori. 1999. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am. J. Physiol. 277: E110-E117.
25. Stickings, P., S. K. Mistry, J. L. Boucher, S. M. Morris, and J. M. Cunningham. 2002. Arginase expression and modulation of IL-1beta-induced nitric oxide generation in rat and human islets of Langerhans. Nitric Oxide 7: 289-296.
26. Tayeh, M. A., and M. A. Marletta. 1989. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate: tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264: 19654-19658.
27. Rosenbaum, J. T., E. L. Howes, Jr., and D. English. 1985. Ascorbate in aqueous humor protects against myeloperoxidase-induced oxidation. Am. J. Pathol. 120: 244-247.
28. Lam, K. W., P. Lee, and R. Fox. 1976. Aqueous ascorbate concentration in hereditary buphthalmic rabbits. Arch. Ophthalmol. 94: 1565-1567.
29. Nakai, K., M. Urushihara, Y. Kubota, and H. Kosaka. 2003. Ascorbate enhances iNOS activity by increasing tetrahydrobiopterin in RAW 264.7 cells. Free Radic. Biol. Med. 35: 929-937.
30. Kleinbongard, P., T. Rassaf, A. Dejam, S. Kerber, and M. Kelm. 2002. Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol. 359: 158-168.
31. Taylor, A. W., J. W. Streilein, and S. W. Cousins. 1994. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153: 1080-1086.
32. May, J. M., L. Li, Z. C. Qu, and J. Huang. 2005. Ascorbate uptake and antioxidant function in peritoneal macrophages. Arch. Biochem. Biophys. 440: 165-172.
33. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138.
34. Szabó, C., H. Ischiropoulos, and R. Radi. 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6: 662-680.